Targeting the HER family with Pan-HER effectively overcomes resistance to cetuximab. (December 2016) - Iida, M.; Bahrar, H.; Brand, T.; Pearson, H.; Coan, J.; Orbuch, R.; Flanigan, B.; Swick, A.; Prabakaran, P.; Lantto, J.; Horak, I.; Kragh, M.; et al.